Sandbox reserve 103
From Proteopedia
(Difference between revisions)
(Replacing page with '<Structure load='1mp8' size='500' frame='true' align='right' caption='Insert caption here' scene='Insert optional scene name here' />') |
|||
| (22 intermediate revisions not shown.) | |||
| Line 1: | Line 1: | ||
| - | < | + | >One of the [[CBI Molecules]] being studied in the [http://www.umass.edu/cbi/ University of Massachusetts Amherst Chemistry-Biology Interface Program] at UMass Amherst in the Peyton group and on display at the [http://www.molecularplayground.org Molecular Playground]. |
| + | <applet load='3omv' size='[450,338]' frame='true' align='right' | ||
| + | caption='C-Raf (3omv)' scene=''User:Thuy V. Nguyen/Sandbox103/Loadedfrompdb/4'/> | ||
| + | '''C-Raf''' (Raf1) is one of the isoforms of Raf serine/threonine kinase. The others are A-Raf and B-Raf. The Raf-kinase is activated by Ras protein. Activated Raf will trigger the phosphorylation of MEK and ERK, which regulates some transcription factors that induce gene expression required for cell proliferation. Raf1 activation is found in 50% of renal cell carcinoma and 100% of hepatocellular carcinoma (Scott Wilhelm et al., 2006). [[Sorafenib]] is an FDA approval small molecule for Raf1 inhibitor. | ||
Current revision
>One of the CBI Molecules being studied in the University of Massachusetts Amherst Chemistry-Biology Interface Program at UMass Amherst in the Peyton group and on display at the Molecular Playground.
|
C-Raf (Raf1) is one of the isoforms of Raf serine/threonine kinase. The others are A-Raf and B-Raf. The Raf-kinase is activated by Ras protein. Activated Raf will trigger the phosphorylation of MEK and ERK, which regulates some transcription factors that induce gene expression required for cell proliferation. Raf1 activation is found in 50% of renal cell carcinoma and 100% of hepatocellular carcinoma (Scott Wilhelm et al., 2006). Sorafenib is an FDA approval small molecule for Raf1 inhibitor.
